These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36196299)

  • 1. Effectiveness and Optimal Duration of Adjunctive Rifampin Treatment in the Management of
    Suzuki H; Goto M; Nair R; Livorsi DJ; Sekar P; Ohl ME; Diekema DJ; Perencevich EN; Alexander B; Jones MP; McDaniel JS; Schweizer ML
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac473. PubMed ID: 36196299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to
    Becker A; Kreitmann L; Triffaut-Fillit C; Valour F; Mabrut E; Forestier E; Lesens O; Cazorla C; Descamps S; Boyer B; Chidiac C; Lustig S; Montbarbon E; Batailler C; Ferry T
    J Bone Jt Infect; 2020; 5(1):28-34. PubMed ID: 32117687
    [No Abstract]   [Full Text] [Related]  

  • 3. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
    Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
    Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study.
    Lesens O; Ferry T; Forestier E; Botelho-Nevers E; Pavese P; Piet E; Pereira B; Montbarbon E; Boyer B; Lustig S; Descamps S;
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1949-1956. PubMed ID: 30083889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truth in DAIR: Duration of Therapy and the Use of Quinolone/Rifampin-Based Regimens After Debridement and Implant Retention for Periprosthetic Joint Infections.
    Tai DBG; Berbari EF; Suh GA; Lahr BD; Abdel MP; Tande AJ
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac363. PubMed ID: 36072695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a New Antibiotic Scheme Improve the Outcome of
    Auñón Á; Tovar-Bazaga M; Blanco-García A; García-Cañete J; Parrón R; Esteban J
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implant Removal in the Management of Prosthetic Joint Infection by
    Gómez-Junyent J; Lora-Tamayo J; Baraia-Etxaburu J; Sánchez-Somolinos M; Iribarren JA; Rodriguez-Pardo D; Praena-Segovia J; Sorlí L; Bahamonde A; Riera M; Rico A; Del Toro MD; Morata L; Cobo J; Falgueras L; Benito N; Muñez E; Jover-Sáenz A; Pigrau C; Ariza J; Murillo O
    Antibiotics (Basel); 2021 Jan; 10(2):. PubMed ID: 33530523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic therapy duration for prosthetic joint infections treated by Debridement and Implant Retention (DAIR): Similar long-term remission for 6 weeks as compared to 12 weeks.
    Chaussade H; Uçkay I; Vuagnat A; Druon J; Gras G; Rosset P; Lipsky BA; Bernard L
    Int J Infect Dis; 2017 Oct; 63():37-42. PubMed ID: 28804007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group.
    Espíndola R; Vella V; Benito N; Mur I; Tedeschi S; Zamparini E; Hendriks JGE; Sorlí L; Murillo O; Soldevila L; Scarborough M; Scarborough C; Kluytmans J; Ferrari MC; Pletz MW; Mcnamara I; Escudero-Sanchez R; Arvieux C; Batailler C; Dauchy FA; Liu WY; Lora-Tamayo J; Praena J; Ustianowski A; Cinconze E; Pellegrini M; Bagnoli F; Rodríguez-Baño J; Del Toro MD;
    Infect Dis Ther; 2022 Dec; 11(6):2177-2203. PubMed ID: 36242742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debridement, antimicrobials, and implant retention in the treatment of late acute and early acute
    Huotari K; Vuorinen M; Vasara A
    Infect Dis (Lond); 2023 Aug; 55(8):525-532. PubMed ID: 37255321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Sex on the Outcomes of Prosthetic Joint Infection Treatment with Debridement, Antibiotics and Implant Retention: A Systematic Review and Individual Patient Data Meta-analysis.
    Choong AL; Shadbolt C; Choong E; Spelman T; Muñoz-Mahamud E; Lora-Tamayo J; Kim K; Wouthuyzen-Bakker M; Spangehl M; Chayakulkeeree M; Young SW; Choong PFM; Dowsey MM
    J Am Acad Orthop Surg Glob Res Rev; 2022 Nov; 6(11):. PubMed ID: 36733983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Long-Term Antibiotic Suppression in the Management of Peri-Prosthetic Joint Infections Treated With Debridement, Antibiotics, and Implant Retention: A Systematic Review.
    Malahias MA; Gu A; Harris EC; Adriani M; Miller AO; Westrich GH; Sculco PK
    J Arthroplasty; 2020 Apr; 35(4):1154-1160. PubMed ID: 31955984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy.
    Cobo J; Miguel LG; Euba G; Rodríguez D; García-Lechuz JM; Riera M; Falgueras L; Palomino J; Benito N; del Toro MD; Pigrau C; Ariza J
    Clin Microbiol Infect; 2011 Nov; 17(11):1632-7. PubMed ID: 20678178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Recurrent
    Singh N; Nair R; Goto M; Carvour ML; Carnahan R; Field EH; Lenert P; Vaughan-Sarrazin M; Schweizer ML; Perencevich EN
    Open Forum Infect Dis; 2019 Nov; 6(11):ofz451. PubMed ID: 31737738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome.
    Byren I; Bejon P; Atkins BL; Angus B; Masters S; McLardy-Smith P; Gundle R; Berendt A
    J Antimicrob Chemother; 2009 Jun; 63(6):1264-71. PubMed ID: 19336454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Acute Periprosthetic Infections with DAIR (Debridement, Antibiotics and Implant Retention) - Success Rate and Risk Factors of Failure].
    Abrman K; Musil D; Stehlík J
    Acta Chir Orthop Traumatol Cech; 2019; 86(3):181-187. PubMed ID: 31333181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.
    Puhto AP; Puhto T; Niinimäki T; Ohtonen P; Leppilahti J; Syrjälä H
    Int Orthop; 2015 Sep; 39(9):1785-91. PubMed ID: 26138772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic outcome of spinal implant infections caused by Staphylococcus aureus: A retrospective observational study.
    Cho OH; Bae IG; Moon SM; Park SY; Kwak YG; Kim BN; Yu SN; Jeon MH; Kim T; Choo EJ; Lee EJ; Kim TH; Choi SH; Chung JW; Kang KC; Lee JH; Lee YM; Lee MS; Park KH
    Medicine (Baltimore); 2018 Oct; 97(40):e12629. PubMed ID: 30290637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Debridement, Antibiotics, and Implant Retention in Periprosthetic Joint Infection: What Predicts Success or Failure?
    Toh RX; Yeo ZN; Liow MHL; Yeo SJ; Lo NN; Chen JY
    J Arthroplasty; 2021 Oct; 36(10):3562-3569. PubMed ID: 34116912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Prior Failed Debridement Compromise the Outcome of Subsequent Two-Stage Revision Done for Periprosthetic Joint Infection Following Total Knee Arthroplasty?
    Rajgopal A; Panda I; Rao A; Dahiya V; Gupta H
    J Arthroplasty; 2018 Aug; 33(8):2588-2594. PubMed ID: 29627258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.